as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹1,060.6
Change
-10.4 (-0.97%)
Open
₹1,078.5
Prev. Close
₹1,071.0
Day High
₹1,080.2
Day Low
₹1,051.0
Volume Analysis
Traded
33,156
Delivered
17,129
Delivery %
51.66%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Strong operating margin (22.0%)
Weaknesses (1)
- •Promoter holding is falling
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹1,106.06 | ₹1,093.13 | ₹1,076.86 | ₹1,063.93 | ₹1,047.66 | ₹1,034.73 | ₹1,018.46 |
| Fibonacci | ₹1,093.13 | ₹1,081.98 | ₹1,075.08 | ₹1,063.93 | ₹1,052.78 | ₹1,045.88 | ₹1,034.73 |
| Camarilla | ₹1,068.63 | ₹1,065.95 | ₹1,063.28 | ₹1,063.93 | ₹1,057.92 | ₹1,055.25 | ₹1,052.57 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-16.0%
1 Week
-4.54%
1 Month
-13.97%
3 Months
-2.17%
6 Months
+22.04%
1 Year
-36.08%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹944.28
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
11.74%
Net margin 10.32% × asset turnover 0.72x × equity multiplier 1.58x
Company Overview
Sector
Chemicals
Market Cap
₹4,718 Cr
P/E (TTM)
17.4
ROE
16.0%
Book Value
₹515.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 24 Sep 2026. Not investment advice.
TopFund Analysis
Epigral Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 59/100. The strongest factor is Financial Strength (100/100), while Momentum (30/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (22.0%); promoter holding is falling.
TopFund Score — Fundamentals Quality
59/100 — AverageData confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- −Debtor days have increased from 42.4 to 60.2 days.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
The officials of the Company are participating in Anand Rathi Annual Flagship Conference: G-200 Summit 2026 scheduled on 21.09.2026.
Epigral Limited has informed about Investor / Analyst Plant Visit on Thursday, 03.09.2026
Epigral Limited has informed about One-on-One Meeting with Investor / Analyst on thursday, 20.08.2026
The officials of the Company are participating in EMKAY Confluence 2026 on 12th August, 2026
Epigral Limited submits Transcript of Conference Call discussing Q1 FY27 Results.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 455 | 478 | 472 | 525 | 651 | 626 | 645 | 628 | 607 | 587 | 597 | 736 | 705 |
| Expenses + | 360 | 370 | 349 | 369 | 475 | 448 | 463 | 454 | 443 | 455 | 494 | 569 | 526 |
| Operating Profit | 95 | 108 | 123 | 155 | 176 | 178 | 183 | 173 | 163 | 132 | 103 | 168 | 179 |
| OPM % | 21.0% | 23.0% | 26.0% | 30.0% | 27.0% | 28.0% | 28.0% | 28.0% | 27.0% | 22.0% | 17.0% | 23.0% | 25.0% |
| Other Income + | 2 | 1 | 2 | 2 | 2 | 6 | 4 | 4 | 9 | 2 | 6 | -1 | 5 |
| Interest | 18 | 21 | 20 | 14 | 14 | 27 | 0 | 12 | 23 | 22 | 11 | 16 | 7 |
| Depreciation | 31 | 32 | 31 | 30 | 33 | 32 | 33 | 34 | 42 | 42 | 43 | 42 | 43 |
| Profit before tax | 47 | 56 | 74 | 113 | 131 | 125 | 154 | 131 | 107 | 70 | 55 | 110 | 134 |
| Tax % | 34.0% | 32.0% | 34.0% | 32.0% | 34.0% | 35.0% | 33.0% | 34.0% | -50.0% | 26.0% | 28.0% | 26.0% | 25.0% |
| Net Profit + | 32 | 38 | 49 | 77 | 86 | 81 | 104 | 87 | 161 | 51 | 39 | 81 | 100 |
| EPS in Rs | 8 | 9 | 12 | 19 | 21 | 20 | 24 | 20 | 37 | 12 | 9 | 19 | 23 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales + | 829 | 1,551 | 2,188 | 1,929 | 2,550 | 2,527 | 2,626 |
| Expenses + | 567 | 1,041 | 1,499 | 1,448 | 1,839 | 1,961 | 2,044 |
| Operating Profit | 261 | 509 | 689 | 481 | 711 | 566 | 582 |
| OPM % | 32.0% | 33.0% | 31.0% | 25.0% | 28.0% | 22.0% | 22.0% |
| Other Income + | 2 | 4 | 8 | 7 | 16 | 15 | 11 |
| Interest | 29 | 44 | 66 | 73 | 53 | 72 | 56 |
| Depreciation | 74 | 86 | 109 | 124 | 133 | 168 | 170 |
| Profit before tax | 161 | 383 | 522 | 291 | 541 | 341 | 367 |
| Tax % | 37.0% | 34.0% | 32.0% | 33.0% | 34.0% | 3.0% | — |
| Net Profit + | 101 | 253 | 353 | 196 | 358 | 332 | 271 |
| EPS in Rs | 24 | 61 | 85 | 47 | 83 | 77 | 63 |
| Dividend Payout % | 0.0% | 0.0% | 6.0% | 11.0% | 7.0% | 6.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Reserves | 432 | 684 | 1,028 | 1,213 | 1,861 | 2,178 |
| Borrowings + | 753 | 993 | 879 | 964 | 593 | 572 |
| Other Liabilities + | 222 | 405 | 484 | 576 | 655 | 712 |
| Total Liabilities | 1,449 | 2,124 | 2,432 | 2,794 | 3,152 | 3,505 |
| Fixed Assets + | 1,102 | 1,068 | 1,804 | 1,767 | 2,238 | 2,117 |
| CWIP | 126 | 589 | 158 | 483 | 64 | 451 |
| Investments | 0 | 0 | 21 | 21 | 98 | 23 |
| Other Assets + | 221 | 467 | 450 | 524 | 752 | 915 |
| Total Assets | 1,449 | 2,124 | 2,432 | 2,794 | 3,152 | 3,505 |
| Equity Capital | 42 | 42 | 42 | 42 | 43 | 43 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 229 | 284 | 626 | 398 | 441 | 436 |
| Cash from Investing Activity + | -197 | -455 | -437 | -401 | -262 | -355 |
| Cash from Financing Activity + | -32 | 195 | -200 | -8 | -164 | -94 |
| Net Cash Flow | 1 | 24 | -11 | -11 | 15 | -14 |
| CFO/OP | 99 | 68 | 106 | 93 | 78 | 90 |
| Free Cash Flow | 32 | -172 | 210 | -1 | 254 | 50 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 27.4% | 27.37% | 27.1% | 26.75% | 25.12% | 23.71% | 23.34% | 23.3% | 23.52% | 23.67% | 24.71% | 24.56% |
| Promoters | 71.38% | 71.38% | 71.49% | 71.58% | 71.58% | 68.94% | 68.95% | 68.83% | 68.83% | 68.83% | 68.83% | 68.83% |
| Government | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
| FII | 1.14% | 1.17% | 1.36% | 1.46% | 2.1% | 3.01% | 3.01% | 3.06% | 2.71% | 2.36% | 1.54% | 1.03% |
| DII | 0.04% | 0.05% | 0.02% | 0.18% | 1.17% | 4.31% | 4.66% | 4.78% | 4.93% | 5.13% | 4.9% | 5.56% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Epigral Limited (this stock) | 4,718 | 17.4 | 2.12 | 16.0% |
| Vishnu Chemicals Limited | 4,696 | 31.4 | 4.39 | 14.3% |
| Gujarat Alkalies & Chem | 4,605 | 69.4 | 0.89 | -0.05% |
| Foseco India Ltd | 4,868 | 46.7 | 4.7 | 12.6% |
| Prasol Chemicals Limited | 4,474 | 103.0 | — | 12.6% |
| Laxmi Organic Indus Ltd | 5,039 | 40.1 | 2.53 | 4.11% |
| Dhanuka Agritech Ltd | 4,385 | 15.0 | 3.16 | 22.0% |
Which Mutual Funds Hold Epigral Limited?
Frequently Asked Questions about Epigral Limited
Epigral Limited (EPIGRAL) closed at ₹1,060.6 on NSE on 25 September 2026, down 10.4 (0.97%) from the previous close.
Epigral Limited trades on the NSE (National Stock Exchange of India) under the symbol EPIGRAL.
Epigral Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 17.4.
Epigral Limited has a dividend yield of 0.46%.
Epigral Limited's 52-week high is ₹1,771.0 and its 52-week low is ₹806.0.
Epigral Limited has a market capitalisation of ₹4,718 crore.
Epigral Limited has a TopFund Quality Score of 59/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Epigral Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.